Trehalose-Free Spray-Dried Thrombin for Rapid Reconstitution

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current hemostatic compositions for preventing excessive bleeding and promoting healing are time-consuming to reconstitute, often require additional additives like trehalose, and may not be tolerable to all patients, while existing hemostatic agents made of non-biodegradable materials can cause undesirable side effects.

Innovation Solution

A spray-dried powdered thrombin material is developed, containing 2.2% to 2.5% albumin without trehalose or mannitol, which can be reconstituted quickly and effectively, maintaining thrombin activity and stability, and can be administered with biologically compatible polymers like gelatin to form a hydrogel.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If aqueous carrier or hydrogel composition is used for hemostatic agents, then biocompatibility and release characteristics can be optimized, but reconstitution time becomes too long for emergency situations

Engineering Contradiction:
ImprovebiocompatibilityVSAvoidreconstitution time
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The invention utilizes phase transition by providing hemostatic agents in a dry powder form that rapidly transitions to an aqueous hydrogel state upon contact with blood or moisture at the bleeding site. This eliminates the need for pre-reconstitution while maintaining the biocompatible hydrogel properties, thus resolving the contradiction between biocompatibility and reconstitution time.

Inventive Principle:
Principle #36Phase transitions

2Productivity

If additional additives like trehalose are added to improve reconstitution times and stability, then product performance is enhanced, but patient tolerance problems arise due to ingredient complexity

Engineering Contradiction:
Improvereconstitution speedVSAvoidproduct composition
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The invention extracts and eliminates unnecessary additives like trehalose and mannitol from the hemostatic agent formulation. By using only essential components (thrombin, calcium chloride, and stabilizing proteins), the product achieves rapid reconstitution and stability without the complexity and potential intolerance issues associated with multiple additives.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The invention changes the formulation parameters by reducing the albumin content to a specific range (2.2%-2.5% by weight) and eliminating carbohydrates entirely. This parameter optimization allows the product to achieve both rapid reconstitution and stability without requiring additional stabilizing sugars, thus resolving the contradiction between reconstitution speed and composition complexity.

Inventive Principle:
Principle #35Parameter changes

3Reliability

If non-biodegradable barrier materials are used to prevent bleeding, then hemostatic effect is achieved, but undesirable side effects occur due to material persistence in the body

Engineering Contradiction:
Improvehemostatic effectVSAvoidside effects from non-biodegradable materials
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The invention uses a composite formulation combining thrombin (active hemostatic agent), calcium chloride (coagulation factor), and stabilizing proteins (albumin). This composite material provides effective hemostasis while being fully biocompatible and biodegradable, eliminating the harmful persistence effects of non-biodegradable barrier materials while maintaining reliable hemostatic effect.

Inventive Principle:
Principle #40Composite materials

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The spray-dried thrombin composition achieves rapid reconstitution in under 60 seconds, maintains thrombin activity, and provides effective hemostasis without the need for additional stabilizing sugars, demonstrating stability and efficacy comparable to commercial formulations.

Implementation Method 1

The thrombin material is aseptically spray-dried and does not require the addition of trehalose or a similar carbohydrate

Methodology Applied
Scientific EffectSpray-drying:

Implementation Method 2

can be administered with biologically compatible polymers like gelatin to form a hydrogel

Methodology Applied
Scientific EffectHydrogel formation: Hydrogel

Implementation Method 3

The spray-dried thrombin composition achieves rapid reconstitution in under 60 seconds, maintains thrombin activity, and provides effective hemostasis without the need for additional stabilizing sugars

Methodology Applied
Scientific EffectProtein stabilization:

Implementation Method 4

Preventing excessive bleeding and promoting healing is an important aspect of many medical procedures

Methodology Applied
Scientific EffectCoagulation: Coagulation

Data Source

PatentEP3731885B1Spray-dried thrombin
Publication Date: 2025.10.08 BAXTER INT INC
  • EP3731885B1 patent drawingFigure 1
  • EP3731885B1 patent drawingFigure 2
  • EP3731885B1 patent drawingFigure 3

AI summary

Spray-dried thrombin materials obtained from feedstock solutions comprising less than 5% by weight albumin and excluding trehalose or other excipients as well as methods of manufacturing the thrombin materials and methods of treating bleeding wounds are disclosed. The methods of use include applying reconstituted spray-dried thrombin topically to a bleeding site, optionally in conjunction with gelatin.